166 related articles for article (PubMed ID: 12909230)
1. Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification.
Hasegawa M; Kojima M; Shioya M; Tamaki Y; Saitoh J; Sakurai H; Kitamoto Y; Suzuki Y; Niibe H; Nakano T
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):172-6. PubMed ID: 12909230
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy in the Management of Orbital Lymphoma: A Single Institution's Experience Over 4 Decades.
Kharod SM; Herman MP; Morris CG; Lightsey J; Mendenhall WM; Mendenhall NP
Am J Clin Oncol; 2018 Jan; 41(1):100-106. PubMed ID: 26398063
[TBL] [Abstract][Full Text] [Related]
3. Curative radiotherapy for primary orbital lymphoma.
Bhatia S; Paulino AC; Buatti JM; Mayr NA; Wen BC
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):818-23. PubMed ID: 12377334
[TBL] [Abstract][Full Text] [Related]
4. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
[TBL] [Abstract][Full Text] [Related]
5. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy.
Parikh RR; Moskowitz BK; Maher E; Della Rocca D; Della Rocca R; Culliney B; Shapira I; Grossbard ML; Harrison LB; Hu K
Leuk Lymphoma; 2015 May; 56(5):1266-70. PubMed ID: 25356924
[TBL] [Abstract][Full Text] [Related]
7. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
[TBL] [Abstract][Full Text] [Related]
8. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
[TBL] [Abstract][Full Text] [Related]
9. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
[TBL] [Abstract][Full Text] [Related]
10. Primary radiotherapy for localized orbital MALT lymphoma.
Le QT; Eulau SM; George TI; Hildebrand R; Warnke RA; Donaldson SS; Hoppe RT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):657-63. PubMed ID: 11849787
[TBL] [Abstract][Full Text] [Related]
11. Partial orbit irradiation achieves excellent outcomes for primary orbital lymphoma.
Binkley MS; Hiniker SM; Donaldson SS; Hoppe RT
Pract Radiat Oncol; 2016; 6(4):255-261. PubMed ID: 26935235
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
König L; Stade R; Rieber J; Debus J; Herfarth K
Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
[TBL] [Abstract][Full Text] [Related]
13. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases.
Demirci H; Shields CL; Karatza EC; Shields JA
Ophthalmology; 2008 Sep; 115(9):1626-31, 1631.e1-3. PubMed ID: 18440641
[TBL] [Abstract][Full Text] [Related]
14. Indolent stage IE non-Hodgkin's lymphoma of the orbit: results after primary radiotherapy.
Bischof M; Zierhut D; Neuhof D; Karagiozidis M; Treiber M; Roeder F; Debus J; Krempien R
Ophthalmologica; 2007; 221(5):348-52. PubMed ID: 17728558
[TBL] [Abstract][Full Text] [Related]
15. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.
Pelloski CE; Wilder RB; Ha CS; Hess MA; Cabanillas FF; Cox JD
Radiother Oncol; 2001 May; 59(2):145-51. PubMed ID: 11325442
[TBL] [Abstract][Full Text] [Related]
16. Low-dose radiotherapy for lymphoid lesions of the orbit and ocular adnexa.
Kennerdell JS; Flores NE; Hartsock RJ
Ophthalmic Plast Reconstr Surg; 1999 Mar; 15(2):129-33. PubMed ID: 10189642
[TBL] [Abstract][Full Text] [Related]
17. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
[TBL] [Abstract][Full Text] [Related]
18. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
Goda JS; Le LW; Lapperriere NJ; Millar BA; Payne D; Gospodarowicz MK; Wells W; Hodgson DC; Sun A; Simpson R; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e659-66. PubMed ID: 21640514
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy is successful treatment for orbital lymphoma.
Smitt MC; Donaldson SS
Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):59-66. PubMed ID: 8482631
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization.
Lee J; Yoon JS; Kim JS; Koom WS; Cho J; Suh CO
Jpn J Clin Oncol; 2019 Jul; 49(7):664-670. PubMed ID: 31505651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]